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Matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) mass spectrometry (MS) has revolutionized the identi-
fication of clinical bacterial and yeast isolates. However, data describing the reproducibility of MALDI-TOF MS for microbial
identification are scarce. In this study, we show that MALDI-TOF MS-based microbial identification is highly reproducible and
can tolerate numerous variables, including differences in testing environments, instruments, operators, reagent lots, and sample
positioning patterns. Finally, we reveal that samples of bacterial and yeast isolates prepared for MALDI-TOF MS identification
can be repeatedly analyzed without compromising organism identification.
Matrix-assisted laser desorption ionization–time of flight(MALDI-TOF) mass spectrometry (MS) has revolutionized
the identification of microorganisms in the clinical microbiology
laboratory, and numerous studies have documented the superior
analytical performance characteristics of MALDI-TOF MS com-
pared to those of manual and automated biochemical methods for
microorganism identification (1–4). Compared to biochemical-
based identification, MALDI-TOF MS-based identification signif-
icantly reduces the cost and time to microbial identification while
simultaneously enhancing favorable patient outcomes and reduc-
ing the cost and length of hospitalization (5–8).
Despite the implementation of MALDI-TOF MS in clinical
microbiology laboratories, studies specifically designed to assess
the reproducibility of MALDI-TOF MS platforms for microor-
ganism identification are limited. As part of a multicenter study,
using the manufacturer’s default unmodified settings, we assessed
the ability of a MALDI-TOF MS platform, the Vitek MS version
2.0 system (bioMérieux, Durham, NC, USA), to reproducibly
identify bacterial and yeast isolates at three different sites. We
probed variations in operators, reagent lots, and sample position-
ing patterns. Finally, the reproducibility of microbial identifica-
tion after initial analysis (initial read) of the samples compared to
repeat analysis (reread) of the same samples was investigated. The
rereading of samples may be of importance in instances when the
definition of additional microbiological characteristics is re-
quired, e.g., in the detection of antimicrobial resistance determi-
nants, or when the initial read failed due to operator or instrument
error.
Over five different days, reproducibility studies were performed
with three independent Vitek MS version 2.0 systems located at three
geographically distinct sites in the United States: site 1 was in Mis-
souri, site 2 was in New York, and site 3 was in California. At each site,
two different operators conducted reproducibility testing. All isolates
were applied to target slides (bioMérieux) using disposable loops
(Sarstedt, Newton, NC, USA). For bacterial isolates, 1 l of matrix
solution (-cyano-4-hydroxycinnamic acid; bioMérieux) was over-
laid and allowed to dry at room temperature before analysis. Prior to
the application of 1l of matrix solution, yeast isolates were lysed on
the target slide by direct application of 0.5 l of formic acid (25%
[vol/vol]; bioMérieux) according to the manufacturer’s recom-
mendations. The testing of samples was conducted using a defined
algorithm: if an identification result was recorded and data acqui-
sition was acceptable, the identification was accepted. If no iden-
tification was recorded (i.e., the organism was not identified) and
data acquisition was acceptable, the result was accepted as not
identified. Finally, if no identification was recorded due to acqui-
sition of a bad spectrum (typically due to inadequate sample prep-
aration), the sample was reapplied in the same position on a new
target slide and the analysis repeated once.
Bacterial isolates were cultured aerobically on Trypticase soy
agar with 5% (vol/vol) sheep blood (Thermo Scientific [Remel],
Lenexa, KS, USA) for 18 to 24 h at 35 to 37°C, while yeast isolates
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were cultured aerobically on Sabouraud’s dextrose agar, Emmons’
modification (Thermo Scientific [Remel]) for 24 to 72 h at 25 to
37°C. A collection of 10 blinded isolates (labeled R1 to R10) was
analyzed at all sites on each day of testing. The collection was
composed of well-characterized organisms to ensure that organ-
ism identification in response to variations in testing environ-
ments, instruments, operators, reagents, sample positioning pat-
terns, and initial and repeat reading of samples could be accurately
assessed. Therefore, the collection included nine isolates obtained
from the American Type Culture Collection (ATCC) (Manassas,
VA, USA): Enterobacter aerogenes ATCC 13048 (R1), Escherichia
coli ATCC 8739 (R2), Klebsiella pneumoniae (specifically, K. pneu-
moniae subsp. ozaenae) ATCC 11296 (R3), Proteus mirabilis
ATCC 29906 (R4), Pseudomonas aeruginosa ATCC 10145 (R5),
Staphylococcus aureus ATCC 29213 (R6), Streptococcus agalactiae
ATCC 13813 (R7), Klebsiella oxytoca ATCC 13182 (R8), and Can-
dida glabrata ATCC MYA-2950 (R10); and an isolate from the
Centraalbureau voor Schimmelcultures (CBS) (Utrecht, The
Netherlands), Candida albicans CBS 5703 (R9). Of the 10 isolates,
only two of the isolates were not used to generate the organism
database, K. pneumoniae ATCC 11296 and C. albicans CBS 5703,
which is a possible limitation of the study.
At each site, two independent testing runs were performed
daily (for a total of 10 testing runs over 5 days at each site). In the
first run, isolates were applied to the target slide in duplicate (thus,
two replicates of each isolate) in sequential order by sample num-
ber (e.g., R1 to R10) by one operator, while in a second separate
run, the isolates were applied to the target slide, again in duplicate,
in random order by a second operator. Hence, a single isolate was
applied to a target slide four times a day at each site and 12 times a
day at all three sites. For every run the instruments were calibrated
with a calibrant strain, E. coli ATCC 8739. Quality control organ-
isms (E. aerogenes ATCC 13048, K. oxytoca ATCC 13182, P.
aeruginosa ATCC 10145, S. aureus ATCC 29213, and C. glabrata
ATCC MYA-2950) and a negative control (matrix only) were also
tested by each technologist every day of testing.
Three different lots of matrix solution and formic acid (re-
agents) and target slides were used by both operators at each site
for sample preparation throughout the 5 days of testing. Reagents
and target slides belonging to lot 1 were used a total of four times
at each site, while lots 2 and 3 were used at each site a total of three
times each. The prepared isolates were analyzed once and data
recorded to generate initial read identification results. Subse-
quently, the isolates were reanalyzed to produce reread results. In
situations in which a sample was repeated due to the initial acqui-
sition of a bad spectrum, the repeat result served as the initial and
only identification result. In theory, each day a single isolate could
be analyzed a total of eight times (four initial reads and four re-
reads) at an individual site and 24 times (12 initial reads and 12
rereads) at all three sites. Therefore, over 5 days each isolate could
be analyzed a total of 40 times (20 initial reads and 20 rereads) at
each site and a total of 120 times (60 initial reads and 60 rereads) at
all three sites. Collectively, for the 10 isolates analyzed at all sites
over the five days of testing, a possible total of 1,200 reads (600
initial reads and 600 rereads) could be recorded. Only species-
level identifications were accepted. All statistical calculations were
performed using SAS 9.3 (SAS, Cary, NC, USA).
For all sites, 598/600 (99.7%) initial read identification results
were correctly identified to the species level. In one instance each,
C. albicans and C. glabrata were not identified, but importantly,
they were not misidentified (Table 1). Upon initial read, two sam-
ples (K. pneumoniae and K. oxytoca) assayed during day three of
testing recorded no identification due to acquisition of a bad spec-
trum. Per our algorithm, the K. pneumoniae and K. oxytoca iso-
lates were reapplied in the same position on another target slide
and analyzed, and the results were recorded as the initial and only
results. Therefore, of 598 possible reread results, 595 (99.5%) were
correctly identified to the species level (Table 2), while one sample
of P. mirabilis and two samples of P. aeruginosa were unidentified
but not misidentified. For the 1,193 combined initial and reread
results that generated an identification, the mean confidence value
for organism identification was 99.84% (standard deviation,
1.24%), thus indicating that the confidence values for organism
identification were reproducibly high. These data clearly indicate
that initial and reread organism identification using the Vitek MS
version 2.0 system is highly reproducible.
To ensure there were no obvious differences in reproducibility
testing between the sites, the results of testing at each site were
analyzed separately. For site 1, 199/200 (99.5%) and 200/200
(100%) of the identification results were correct to the species
level after initial and reread testing, respectively. At site 2, 200/200
(100%) of the initial and 195/198 (98.5%) of the reread results
were correct to the species level. Finally, 199/200 (99.5%) and
200/200 (100%) of the identification results were correct to the
species level at site 3 after initial and reread testing, respectively.
Using Fisher’s exact test to analyze the combined initial and reread
TABLE 1 Reproducibility of organism identification at all sites after initial read of samples
Sample no. Organism




interval (%)1 2 3 4 5
R1 E. aerogenes 12/12 12/12 12/12 12/12 12/12 60/60 (100) 94.0–100
R2 E. coli 12/12 12/12 12/12 12/12 12/12 60/60 (100) 94.0–100
R3 K. pneumoniae 12/12 12/12 12/12 12/12 12/12 60/60 (100) 94.0–100
R4 P. mirabilis 12/12 12/12 12/12 12/12 12/12 60/60 (100) 94.0–100
R5 P. aeruginosa 12/12 12/12 12/12 12/12 12/12 60/60 (100) 94.0–100
R6 S. aureus 12/12 12/12 12/12 12/12 12/12 60/60 (100) 94.0–100
R7 S. agalactiae 12/12 12/12 12/12 12/12 12/12 60/60 (100) 94.0–100
R8 K. oxytoca 12/12 12/12 12/12 12/12 12/12 60/60 (100) 94.0–100
R9 C. albicans 12/12 12/12 11/12 12/12 12/12 59/60 (98.3) 91.1–99.9
R10 C. glabrata 12/12 12/12 11/12 12/12 12/12 59/60 (98.3) 91.1–99.9
Total 120/120 (100) 120/120 (100) 118/120 (98.3) 120/120 (100) 120/120 (100) 598/600 (99.7) 98.8–99.9
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results, no significant difference in organism identification be-
tween the testing sites was observed at the 0.05 level of significance
(P 0.463).
Finally, given that reproducible quality control testing forms
the foundation of all testing in clinical microbiology, we sought to
understand the reproducibility of the quality control testing at all
sites. Upon initial reading, all quality control organisms were cor-
rectly identified to the species level (Table 3), while after reread-
ing, with the exception of oneK. oxytoca sample and twoP. aerugi-
nosa samples, which were unidentified rather than misidentified,
all quality control organisms were correctly identified to the spe-
cies level (Table 3). When analyzed initially, 30/31 (96.8%) of the
negative control (matrix only) samples were not identified, i.e.,
the expected result was achieved. For one of the samples, a Vitek
MS version 2.0 result of mixed genera (Corynebacterium pseudo-
diphtheriticum, Tatumella ptyseos, Bacillus megaterium, and Strep-
tococcus salivarius subsp. thermophilus), which is considered un-
identified, was obtained. The reread result for this sample was no
identification. The initial discordant result may have been due to
extraneous debris on the spot. To unequivocally demonstrate the
absence of contaminating material, the initial testing operator ap-
plied matrix from the same vial to a target slide. The expected
result of no identification after both the initial read and reread of
the sample was obtained, confirming the matrix was not contam-
inated. Unfortunately, due to operator error one of the 31 negative
control samples was not reread; consequently, of 30 possible neg-
ative control reread results, 30 (100%) were not identified (ex-
pected result). For the 301 combined initial read and reread results
that generated an organism identification, the mean confidence
value for organism identification was 99.9% (standard deviation,
0.008%), indicating that the confidence values for quality control
organism identification were reproducibly high. Using Fisher’s
exact test to analyze the combined initial read and reread results,
no significant difference in quality control testing between the
testing sites was observed at the 0.05 level of significance (P 
0.175). Based on these data, it can be concluded that quality con-
trol testing on the Vitek MS version 2.0 system is highly reproduc-
ible.
Prior to this report, data describing the reproducibility of mi-
crobial identification using MALDI-TOF MS were limited. To the
best of our knowledge, only a single multicenter study focused on
the reproducibility of microbial identification using MALDI-TOF
MS has been described (9). The study concentrated on the ability
of different Bruker MALDI-TOF MS platforms (Bruker Dalton-
ics, Billerica, MA, USA) to identify Gram-negative nonfermenta-
tive bacterial isolates at different testing sites. Despite the impor-
tance of the work, yeast isolates were not assayed. In addition,
differences in reagent lots, target slides, sample positioning pat-
terns, and initial read and reread of samples do not appear to have
been tested.
Here, we describe the reproducibility of organism identifica-
tion using the Vitek MS version 2.0 system. We unambiguously
demonstrate that bacterial and yeast identification using the Vitek
MS version 2.0 system is highly reproducible and can tolerate
TABLE 2 Reproducibility of organism identification at all sites after reread of samples
Sample no. Organism




interval (%)1 2 3 4 5
R1 E. aerogenes 12/12 12/12 12/12 12/12 12/12 60/60 (100) 94.0–100
R2 E. coli 12/12 12/12 12/12 12/12 12/12 60/60 (100) 94.0–100
R3 K. pneumoniae 12/12 12/12 11/11a 12/12 12/12 59/59 (100) 93.9–100
R4 P. mirabilis 12/12 12/12 12/12 11/12 12/12 59/60 (98.3) 91.1–99.9
R5 P. aeruginosa 11/12 12/12 12/12 11/12 12/12 58/60 (96.7) 88.5–99.6
R6 S. aureus 12/12 12/12 12/12 12/12 12/12 60/60 (100) 94.0–100
R7 S. agalactiae 12/12 12/12 12/12 12/12 12/12 60/60 (100) 94.0–100
R8 K. oxytoca 12/12 12/12 11/11a 12/12 12/12 59/59 (100) 93.9–100
R9 C. albicans 12/12 12/12 12/12 12/12 12/12 60/60 (100) 94.0–100
R10 C. glabrata 12/12 12/12 12/12 12/12 12/12 60/60 (100) 94.0–100
Total 119/120 (99.2) 120/120 (100) 118/118 (100) 118/120 (98.3) 120/120 (100) 595/598 (99.5) 98.5–99.9
a For one of these samples, the initial read recorded no identification due to acquisition of a bad spectrum. The sample was reapplied in the same position on a new target slide and
analyzed. The repeat result was recorded as the initial and only identification.











S. aureus 31/31 (100) 88.8–100 31/31 (100) 88.8–100
K. oxytoca 30/30 (100) 88.4–100 29/30 (96.7) 82.8–99.9
P. aeruginosa 30/30 (100) 88.4–100 28/30 (93.3) 77.9–99.2
E. aerogenes 30/30 (100) 88.4–100 30/30 (100) 88.4–100
C. glabrata 31/31 (100) 88.8–100 31/31 (100) 88.8–100
Negative control (matrix only) 30/31 (96.8)a 83.3–99.9 30/30 (100) 88.4–100
a For one of these samples, a result of mixed genera (C. pseudodiphtheriticum, T. ptyseos, B. megaterium, and S. salivarius subsp. thermophilus), which is considered unidentified, was
obtained.
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numerous variables, including different testing environments, in-
struments, operators, reagent and target slide lots, and sample
positioning patterns. Furthermore, we show that both initial and
repeat testing of samples is not only possible but highly reproduc-
ible within and between laboratories. This has important practical
implications in a diagnostic microbiology laboratory where sub-
sequent analysis of an isolate may be required to further define key
microbiological characteristics, e.g., in the detection of antimicro-
bial resistance determinants, or as a result of operator or instru-
ment error. In conclusion, MALDI-TOF mass spectrometric-
based microbial identification is highly reproducible in the setting
of the routine clinical microbiology laboratory.
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